VIVUS Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
343,286.00
299,571.00
241,563.00
269,519.00
226,335.00
111,249
Total Accounts Receivable
17,774.00
11,595.00
8,997.00
9,478.00
12,187.00
26,387
Inventories
48,503.00
34,447.00
13,602.00
16,186.00
17,712.00
23,132
Other Current Assets
14,378.00
11,578.00
9,430.00
8,251.00
7,178.00
6,759
Total Current Assets
423,941.00
357,191.00
273,592.00
303,434.00
263,412.00
167,527
Net Property, Plant & Equipment
1,954.00
1,346.00
994.00
788.00
542.00
341
Other Assets
5,901.00
8,401.00
2,616.00
1,554.00
1,014.00
208
Total Assets
431,796.00
366,938.00
277,202.00
305,776.00
264,968.00
302,147
ST Debt & Current Portion LT Debt
-
10,459.00
14,356.00
8,708.00
5,147.00
Accounts Payable
10,759.00
10,430.00
7,060.00
4,707.00
10,072.00
Other Current Liabilities
41,248.00
36,482.00
38,033.00
34,860.00
23,550.00
Total Current Liabilities
52,007.00
57,371.00
59,449.00
48,275.00
38,769.00
Long-Term Debt
213,106.00
217,324.00
217,034.00
232,610.00
230,536.00
Other Liabilities
13,314.00
9,725.00
7,804.00
6,706.00
5,001.00
Total Liabilities
278,427.00
284,420.00
284,287.00
287,591.00
274,306.00
Common Equity (Total)
153,369.00
82,518.00
7,085.00
18,185.00
9,338.00
Total Shareholders' Equity
153,369.00
82,518.00
7,085.00
18,185.00
9,338.00
Total Equity
153,369.00
82,518.00
7,085.00
18,185.00
9,338.00
Liabilities & Shareholders' Equity
431,796.00
366,938.00
277,202.00
305,776.00
264,968.00

About VIVUS

View Profile
Address
900 East Hamilton Avenue
Campbell California 95008
United States
Employees -
Website http://www.vivus.com
Updated 07/08/2019
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. Its products include Qsymia and STENDRA/SPEDRA. The company was founded by Virgil A.